369 related articles for article (PubMed ID: 21620713)
1. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Güzel O; Temperini C; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2008 Jan; 18(1):152-8. PubMed ID: 18024029
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
[TBL] [Abstract][Full Text] [Related]
10. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
[TBL] [Abstract][Full Text] [Related]
11. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase VII is S-glutathionylated without loss of catalytic activity and affinity for sulfonamide inhibitors.
Truppo E; Supuran CT; Sandomenico A; Vullo D; Innocenti A; Di Fiore A; Alterio V; De Simone G; Monti SM
Bioorg Med Chem Lett; 2012 Feb; 22(4):1560-4. PubMed ID: 22277279
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit α- and β-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms.
Marini AM; Maresca A; Aggarwal M; Orlandini E; Nencetti S; Da Settimo F; Salerno S; Simorini F; La Motta C; Taliani S; Nuti E; Scozzafava A; McKenna R; Rossello A; Supuran CT
J Med Chem; 2012 Nov; 55(22):9619-29. PubMed ID: 23067387
[TBL] [Abstract][Full Text] [Related]
15. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D
Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.
Hen N; Bialer M; Yagen B; Maresca A; Aggarwal M; Robbins AH; McKenna R; Scozzafava A; Supuran CT
J Med Chem; 2011 Jun; 54(11):3977-81. PubMed ID: 21506569
[TBL] [Abstract][Full Text] [Related]
17. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1214-21. PubMed ID: 19119014
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
